BBlogFlow

Russian health officials deny reports of 2nd plague death in Siberia - CBC

·Oct 8, 2026

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. CBC

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

‘No plague case’ in Siberia, Russia tells WHO as assessments continue - UN News

HealthHealth authorities in Russia say there is “no plague case” in Siberia following reports last week that a lab technician had died of pneumonia of an unknown origin in the region, World Health Organization (WHO) officials said on Wednesday. Russian regulators told WHO on Tuesday that there was no evidence pneumonic plague played a part in her death and that no pathogens had been detected, agency chief Tedros Adhanom Ghebreyesus said. About 200 of her contacts have been placed in quarantine. Further requests for information have been sent to Russian authorities, he added, noting that the lab is part of an institute in Irkutsk that studies dangerous pathogens, including plague, which occurs naturally in wild animals in the area.

UN News·

Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Medical Xpress·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·